If you typed Bioscience Consulting or Rubén Carnero into a search box, you are probably building a CRO shortlist for a medical-device study in Latin America. This article uses what Bioscience Consulting, Inc. publishes on its own site (www.bioscienceweb.com · www.bioscienceweb.com/clinicaltrials) and public ClinicalTrials.gov records, then compares that offer with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Bioscience Consulting publishes
Bioscience Consulting, Inc. is a Doral, Florida company whose website describes a contract research organization for medical-device technologies in Latin America, with a stated specialty in first-in-human device trials, plus a separate “Growth & Expansion” offer for firms entering or scaling in the regional device market. Planning services listed on the site include project management, site and principal investigator selection, pre-clinical and animal-lab training, site initiation, local legal representative, import and export agent, authorized warehousing, and IRB, ethics-committee and regulatory-agency approvals. Execution services listed include GCP standards, electronic data capture, a clinical coordinator, patient enrollment, procedure support, product accountability, case report forms, monitoring, study closing and reporting. The homepage gives a Doral office address and contact emails for Buenos Aires, São Paulo and Santiago. Florida corporate records list Rubén L. Carnero as president and registered agent of the 2005 Florida corporation; his public LinkedIn headline is President at Bioscience Consulting, Inc. (linkedin.com/in/ruben-carnero-529a27).
The clinical-trials page says the firm has been “supporting the innovation for over 40 years” through “cost-efficient” CRO services. That 40-year figure is the company’s wording; the site does not explain it, and the Florida corporation was filed in 2005. The website does not name sponsors, studies or prices. A 2021 client-logo collage appears on the homepage without a caption of current engagements, so those marks are not treated here as a verified client list. Public ClinicalTrials.gov records independently list Bioscience Consulting, Inc. as a collaborator, not the lead sponsor, on three industry device studies: two CereVasc eShunt pilots at Clínica La Sagrada Familia in Buenos Aires (NCT04758611, NCT05250505) and Erbe’s completed HybridAPC gastric mucosal ablation feasibility study at Hospital das Clínicas, Universidade de São Paulo (NCT05574777, 13 participants). No ClinicalTrials.gov record naming the firm in Chile was found in this review.
Bioscience Consulting vs bioaccess®
| Dimension | Bioscience Consulting | bioaccess® |
|---|---|---|
| Core focus | Medical-device CRO and Latin America market-expansion consultancy, with a first-in-human positioning on its site | First-in-human and early feasibility studies for medical devices |
| Geography | Doral, Florida headquarters; contact emails published for Buenos Aires, São Paulo and Santiago | Latin America, since 2010, from Mexico to Argentina |
| Device FIH track record | No named study on the company website. Public ClinicalTrials.gov records list the firm as a collaborator on three industry device studies in Argentina and Brazil (NCT04758611, NCT05250505, NCT05574777) | Published case studies on bioaccessla.com |
| After the trial | Growth and expansion services on the company site (market development, partner selection, product registration is named on the president’s public LinkedIn profile). No published multi-country sanitary-registration holder product was found | Live multi-country sanitary registration and in-country holder service |
| Public pricing | None published | See the published sample first-in-human budget (illustrative, not a quote) and, for registration, the market-access rate card |
Where each one fits
If you want a Florida-based boutique that already appears as a collaborator on named device studies in Argentina and Brazil, and whose public offer also covers market development in those countries plus a Chile contact email, Bioscience Consulting is a fair shortlist candidate. Confirm the exact role it would play on your protocol, because a ClinicalTrials.gov collaborator line does not, by itself, describe monitoring, legal representation or regulatory scope.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, with over 20 years on complex, advanced cardiovascular technologies and with regulatory agencies across Latin America, from Mexico to Argentina, and running device studies in the region since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including Bioscience Consulting, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the Bioscience Consulting public pages linked above, Florida and Brazilian corporate extracts, the president’s public LinkedIn profile, and ClinicalTrials.gov records NCT04758611, NCT05250505 and NCT05574777, reviewed for bioaccess® competitive research (10 November 2026). Claims on the company site are theirs. No invented sponsors, prices or contacts.
Frequently asked questions
What is Bioscience Consulting, Inc.?
It is a Doral, Florida company whose website, bioscienceweb.com, offers contract research organization services for medical-device technologies in Latin America, including a first-in-human positioning, and a growth-and-expansion offer for regional market entry. Florida records show the corporation was filed in 2005.
Who is Rubén Carnero?
Public Florida filings list Rubén L. Carnero as president and registered agent of Bioscience Consulting, Inc. His public LinkedIn headline is President at Bioscience Consulting, Inc. That is a company leadership role, not a clinical-investigator listing.
Does Bioscience Consulting run first-in-human device trials in Chile, Argentina and Brazil?
The company site lists contact emails in Santiago, Buenos Aires and São Paulo and says it specializes in first-in-human medical-device clinical trials in Latin America. Public ClinicalTrials.gov records reviewed on 10 November 2026 list the firm as a collaborator on device studies in Argentina and Brazil only. No record naming the firm in Chile was found. The registry does not call those three studies first-in-human; two are described as eShunt pilots and one as a safety-and-feasibility study.
Does Bioscience Consulting publish pricing?
No public fee schedule or rate card was found on its website on 10 November 2026. Pricing appears to require a direct quote.